The Molecule Doesn’t Care – Rethinking Chemical Manufacturing

HydGene Head of Engineering Peter Meek continues his LinkedIn series exploring the structural challenges facing modern chemical manufacturing — and why the next generation of industrial systems may look fundamentally different from what came before.

After years working across oil & gas, petrochemical, power, and industrial processing facilities, Peter argues that one core reality sits at the centre of the industry: “The customer doesn’t buy the process. They buy the molecule — and they want it as cheap as possible.”

In his latest article, The Molecule Doesn’t Care, Peter explores how the chemical industry became built around large, centralised infrastructure designed for maximum scale and efficiency — and why new biological manufacturing approaches are starting to challenge that model.

The article examines the shift from: Extract → Process → Ship → Use towards: Capture → Convert → Use (on-site)

As advances in synthetic biology, biocatalysts, and process engineering improve economics, decentralised chemical manufacturing is becoming increasingly viable — particularly where supply-chain resilience and local production matter.

Peter also outlines how HydGene is applying this model in practice:converting low-cost agricultural waste biomass into green hydrogen and chemical derivatives directly where they are needed.

The article explores:

• why “cost parity” is the milestone that matters most

• how biological systems are becoming commercially competitive

• and why future chemical manufacturing may prioritise outputs over traditional process architecture

This is the systems-level challenge HydGene is working to solve.

Peter's series will continue weekly on LinkedIn. Follow Peter Meek and HydGene Renewables to stay across the conversation.